alcon ag - ALC

ALC

Close Chg Chg %
86.96 0.40 0.46%

Closed Market

87.36

+0.40 (0.46%)

Volume: 1.74M

Last Updated:

Jul 18, 2025, 3:59 PM EDT

Company Overview: alcon ag - ALC

ALC Key Data

Open

$88.41

Day Range

86.97 - 88.42

52 Week Range

80.48 - 101.10

Market Cap

$43.01B

Shares Outstanding

494.60M

Public Float

489.33M

Beta

0.95

Rev. Per Employee

N/A

P/E Ratio

38.41

EPS

$2.26

Yield

36.70%

Dividend

$0.33

EX-DIVIDEND DATE

May 14, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

1.54M

 

ALC Performance

1 Week
 
-0.15%
 
1 Month
 
2.28%
 
3 Months
 
-5.61%
 
1 Year
 
-2.96%
 
5 Years
 
46.22%
 

ALC Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 28
Full Ratings ➔

About alcon ag - ALC

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the Surgical and Vision Care segments. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner in 1945 and is headquartered in Geneva, Switzerland.

ALC At a Glance

Alcon AG
Royce Bedward
Geneva, Geneve (Geneva) 1214
Phone 41-817-293-04-50 Revenue 9.91B
Industry Medical Specialties Net Income 1.02B
Sector Health Technology 2024 Sales Growth 4.823%
Fiscal Year-end 12 / 2025 Employees 25,599
View SEC Filings

ALC Valuation

P/E Current 38.415
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 41.192
Price to Sales Ratio 4.258
Price to Book Ratio 1.946
Price to Cash Flow Ratio 20.316
Enterprise Value to EBITDA 17.205
Enterprise Value to Sales 4.592
Total Debt to Enterprise Value 0.113

ALC Efficiency

Revenue/Employee 387,163.561
Income Per Employee 39,767.178
Receivables Turnover 5.122
Total Asset Turnover 0.331

ALC Liquidity

Current Ratio 2.77
Quick Ratio 1.774
Cash Ratio 0.803

ALC Profitability

Gross Margin 55.645
Operating Margin 14.297
Pretax Margin 12.754
Net Margin 10.271
Return on Assets 3.396
Return on Equity 4.827
Return on Total Capital 3.814
Return on Invested Capital 3.91

ALC Capital Structure

Total Debt to Total Equity 23.848
Total Debt to Total Capital 19.256
Total Debt to Total Assets 16.937
Long-Term Debt to Equity 23.046
Long-Term Debt to Total Capital 18.608
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Alcon Ag - ALC

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
8.29B 8.72B 9.46B 9.91B
Sales Growth
+21.34% +5.14% +8.47% +4.82%
Cost of Goods Sold (COGS) incl D&A
3.60B 3.91B 4.20B 4.40B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
1.22B 1.12B 1.22B 1.23B
Depreciation
404.00M 408.00M 476.00M 476.00M
Amortization of Intangibles
815.00M 715.00M 745.00M 752.00M
COGS Growth
-4.15% +8.52% +7.44% +4.64%
Gross Income
4.69B 4.81B 5.25B 5.51B
Gross Income Growth
+52.50% +2.54% +9.30% +4.97%
Gross Profit Margin
+56.54% +55.15% +55.57% +55.65%
2021 2022 2023 2024 5-year trend
SG&A Expense
3.71B 3.65B 4.04B 4.13B
Research & Development
653.00M 702.00M 828.00M 876.00M
Other SG&A
3.06B 2.95B 3.21B 3.25B
SGA Growth
+13.66% -1.59% +10.57% +2.20%
Other Operating Expense
69.00M 176.00M 36.00M (28.00M)
Unusual Expense
329.00M 308.00M 142.00M 4.00M
EBIT after Unusual Expense
580.00M 672.00M 1.04B 1.41B
Non Operating Income/Expense
(42.00M) (75.00M) (18.00M) 43.00M
Non-Operating Interest Income
3.00M 16.00M 45.00M 84.00M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
120.00M 134.00M 189.00M 192.00M
Interest Expense Growth
-3.23% +11.67% +41.04% +1.59%
Gross Interest Expense
120.00M 134.00M 189.00M 192.00M
Interest Capitalized
- - - -
-
Pretax Income
418.00M 463.00M 832.00M 1.26B
Pretax Income Growth
+165.83% +10.77% +79.70% +51.92%
Pretax Margin
+5.04% +5.31% +8.80% +12.75%
Income Tax
42.00M 128.00M (142.00M) 238.00M
Income Tax - Current - Domestic
118.00M 17.00M 74.00M 95.00M
Income Tax - Current - Foreign
116.00M 146.00M 93.00M 239.00M
Income Tax - Deferred - Domestic
(45.00M) (53.00M) (313.00M) (25.00M)
Income Tax - Deferred - Foreign
(147.00M) 18.00M 4.00M (71.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
376.00M 335.00M 974.00M 1.02B
Minority Interest Expense
- - - -
-
Net Income
376.00M 335.00M 974.00M 1.02B
Net Income Growth
+170.81% -10.90% +190.75% +4.52%
Net Margin Growth
+4.54% +3.84% +10.30% +10.27%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
376.00M 335.00M 974.00M 1.02B
Preferred Dividends
- - - -
-
Net Income Available to Common
376.00M 335.00M 974.00M 1.02B
EPS (Basic)
0.7674 0.6817 1.9757 2.0591
EPS (Basic) Growth
+170.67% -11.17% +189.82% +4.22%
Basic Shares Outstanding
490.00M 491.40M 493.00M 494.40M
EPS (Diluted)
0.7621 0.6776 1.9617 2.0462
EPS (Diluted) Growth
+170.18% -11.09% +189.51% +4.31%
Diluted Shares Outstanding
493.40M 494.40M 496.50M 497.50M
EBITDA
2.13B 2.10B 2.40B 2.65B
EBITDA Growth
+32.26% -1.17% +14.22% +10.12%
EBITDA Margin
+25.67% +24.13% +25.40% +26.69%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 106.82
Number of Ratings 28 Current Quarters Estimate 0.798
FY Report Date 09 / 2025 Current Year's Estimate 3.127
Last Quarter’s Earnings 0.71 Median PE on CY Estimate N/A
Year Ago Earnings 3.05 Next Fiscal Year Estimate 3.634
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 16 16 26 26
Mean Estimate 0.80 0.87 3.13 3.63
High Estimates 0.84 0.94 3.27 3.94
Low Estimate 0.75 0.80 3.06 3.14
Coefficient of Variance 3.18 3.96 1.76 4.17

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 18 18 20
OVERWEIGHT 4 4 4
HOLD 5 5 4
UNDERWEIGHT 1 1 1
SELL 0 0 0
MEAN Overweight Overweight Overweight

Alcon Ag in the News